Back to top

SPDR SP BIOTECH: (AMEX : XBI)

(U.S : AMEX) As of Apr 16, 2014 03:59 PM ET

 Add to portfolio

$126.24 USD

+3.55 (2.89%)

Volume: 1,188,215

Zacks ETF Rank: 2 - Buy [?]   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Premium - The only way to get access to the Zacks Rank

ETF Quote Details

Previous Close 122.69
Open 124.51
Bid 125.73
Ask 126.15
Day Low-High 122.40-126.80
52wk Low-High 99.14-172.52
Volume 1,188,215
NAV (month end) 142.42
Premium (+)/Discount (-) (month end)-19.73

Zacks Premium Research for XBI

Zacks ETF Rank [?] Buy 2
ETF Risk [?] High

Learn to Profit from the Zacks Rank

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Premium - The only way to get access to the Zacks Rank

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.51 (0.41%)
Issuer STATE STREET GLOBAL ADVISORS

Benchmark for XBI

SP BIOTECHNOLOGY SELECT INDUSTRY

The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Fund Summary for XBI

SPDR SP BIOTECH

The SPDR S&P Biotech ETF, before expenses, seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index.